½ÃÀ庸°í¼­
»óǰÄÚµå
1339290

Ç×±Õ ÁöÇ÷ Á© ½ÃÀå, Á¡À¯À², ±Ô¸ð, µ¿Çâ ¹× »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦Ç° À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2032³â)

Antibacterial Haemostatic Gels Market Share, Size, Trends, Industry Analysis Report, By Product Type ; By End User; By Region; Segment Forecast, 2023-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 117 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è Ç×±Õ ÁöÇ÷Á¦ ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 24¾ï 5,294¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

Á¦Ç° °³¹ßÀÇ ±ÞÁõÀº ¼¼°è ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä Ãø¸é Áß ÇϳªÀÔ´Ï´Ù. Á¦Á¶¾÷üµéÀº Ç×±Õ ÁöÇ÷ Á©ÀÇ Çõ½ÅÀûÀÎ Á¦ÇüÀ» ¸¸µé±â À§ÇØ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â °íÀ¯ÇÑ Æ¯¼ºÀ» °¡Áø Á©À» °³¹ßÇϱâ À§ÇÑ »õ·Î¿î ¼ººÐ, Á¶ÇÕ ¹× ±â¼ú Ž»öÀÌ Æ÷ÇԵ˴ϴÙ. °¢ ȸ»ç´Â ÀÇ·áÁø°ú ȯÀÚ ¸ðµÎ¿¡°Ô Æí¸®ÇÏ°í ½±°Ô ¹Ù¸¦ ¼ö ÀÖ´Â Ç×±Õ ÁöÇ÷ Á©À» °³¹ßÇϱâ À§ÇØ Áö¼ÓÀûÀ¸·Î ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 4¿ù ¸ÓÅ¥¸®´Â °í¼º´É Ç×±Õ ÁöÇ÷ Á©ÀÎ ·¡ÇÇµå ¾Á(Rapid Seal)À» Ãâ½ÃÇß½À´Ï´Ù. ¸¶Âù°¡Áö·Î ´Ù¸¥ ¸¹Àº ±â¾÷µéµµ ´Ù¾çÇÑ Á¦Ç°¿¡ ÅõÀÚÇÏ¿© ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

´ç´¢º´¼º Á·ºÎ±Ë¾ç, ¿åâ, Á¤¸Æ¼º ÇÏÁö±Ë¾ç°ú °°Àº ¸¸¼º »óó´Â ¼¼°èÀûÀ¸·Î ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Ç×±Õ ÁöÇ÷ Á©Àº ÃâÇ÷À» ¾ïÁ¦Çϰí, °¨¿°À» ¿¹¹æÇϰí, Ä¡À¯¸¦ ÃËÁøÇÏ¿© »óó °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¸¸¼º »óó ¹ß»ý·ü Áõ°¡´Â ÀÌ·¯ÇÑ Á©¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² È¿°úÀûÀÎ »óó °ü¸®ÀÇ Á߿伺¿¡ ´ëÇÑ ´ëÁßÀÇ Àνĵµ Å©°Ô ³ô¾ÆÁ³½À´Ï´Ù. ȯÀÚ¿Í ÀÇ·á Àü¹®°¡µéÀº »óó Ä¡À¯¸¦ À§ÇØ Ç×±Õ ÁöÇ÷ Á©À» »ç¿ëÇÏ´Â °ÍÀÇ ÀÌÁ¡À» Á¡Á¡ ´õ ¸¹ÀÌ ÀνÄÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ö¿ä Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù.

¼±Áø±¹°ú ½ÅÈï±¹ ¸ðµÎ¿¡¼­ ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ Ç×±Õ ÁöÇ÷Á¦ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Á¤ºÎ¿Í ÀÇ·á ±â°üÀº ȯÀÚÀÇ °á°ú¸¦ °³¼±Çϰí ÇÕº´ÁõÀ¸·Î ÀÎÇÑ ÀÇ·á ºñ¿ëÀ» ÁÙÀ̱â À§ÇØ Ç×±Õ ÁöÇ÷ Á©À» Æ÷ÇÔÇÑ Ã·´Ü »óó Ä¡·á Á¦Ç°¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¿¬¹æ Á¤ºÎ(34%)¿Í ¹Î°£ °¡Á¤(27%)ÀÌ Àüü ÀÇ·áºñ¿¡¼­ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖÀ¸¸ç, 2021³â¿¡´Â 4.4% Áõ°¡ÇÑ 13¾ï 2,390¸¸ ´Þ·¯ÀÇ ÀÇ·áºñ ÁöÃâÀÌ ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·áºñ ÁöÃâ Áõ°¡´Â ¼¼°è ÁöÇ÷Á¦ ÆÇ¸Å Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ¼¼°èÀûÀ¸·Î »ó´çÇÑ ¼ºÀå·ü·Î ½ÃÀå ¼ºÀåÀ» ´õ¿í È®´ëÇÒ °ÍÀÔ´Ï´Ù.

Ç×±Õ ÁöÇ÷Á© ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

È¿´É, »ç¿ë ÆíÀǼº, ȯÀÚ °á°ú °³¼±À¸·Î 2022³â ¼Òº¯ ºÐ¼® ŰƮ ºÐ¾ß°¡ ¼¼°è ½ÃÀåÀ» Àå¾ÇÇÒ °ÍÀ¸·Î Àü¸Á

Æø³ÐÀº ¼ö¼ú Áõ°¡·Î 2022³â È£½ºÇÇÅ»¸®Æ¼ ºÐ¾ß°¡ ¸ÅÃâ Á¡À¯À²¿¡¼­ ¿ìÀ§¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î Àü¸Á

°í±Þ ÀÇ·á ÀÎÇÁ¶ó¿Í ±â¼ú ¹ßÀüÀ¸·Î 2022³â ¸»¿¡´Â ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è Ç×±Õ ÁöÇ÷Á¦ ½ÃÀå¿¡´Â DEXX laboratories inc, Medura, StopBleed, Zoetis Inc, Pfizer µîÀÌ Æ÷ÇԵ˴ϴÙ.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ Ç×±Õ ÁöÇ÷ Á© ½ÃÀå¿¡ °üÇÑ ÀλçÀÌÆ®

  • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ¾÷°è ÇöȲ
  • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
  • PESTLE ºÐ¼®
  • Ç×±Õ ÁöÇ÷ Á© ¾÷°è µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ Ç×±Õ ÁöÇ÷ Á© ½ÃÀå, Á¦Ç° À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ´¢ºÐ¼® °Ë»ç ŰƮ
  • Ç÷¾×°Ë»ç ŰƮ
  • Ç÷¾Ð ¸ð´ÏÅ͸µ ±â±â
  • Ç÷´ç ÃøÁ¤ Àåºñ
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ Ç×±Õ ÁöÇ÷ Á© ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ÀçÅÃÄ¡·á
  • Áø´Ü¼¾ÅÍ
  • º´¿ø
  • Ŭ¸®´Ð
  • ±âŸ

Á¦7Àå Áö¿ª ¼¼°èÀÇ Ç×±Õ ÁöÇ÷ Á© ½ÃÀå

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå Æò°¡, Áö¿ª, 2019-2032³â
  • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ºÏ¹Ì
    • ºÏ¹Ì : Ç×±Õ ÁöÇ÷ Á© ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
    • ºÏ¹Ì : Ç×±Õ ÁöÇ÷ Á© ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ¹Ì±¹
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ij³ª´Ù
  • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - À¯·´
    • À¯·´ : Ç×±Õ ÁöÇ÷ Á© ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
    • À¯·´ : Ç×±Õ ÁöÇ÷ Á© ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ¿µ±¹
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ÇÁ¶û½º
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - µ¶ÀÏ
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ÀÌÅ»¸®¾Æ
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ½ºÆäÀÎ
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ³×´ú¶õµå
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ·¯½Ã¾Æ
  • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Ç×±Õ ÁöÇ÷ Á© ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Ç×±Õ ÁöÇ÷ Á© ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - Áß±¹
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - Àεµ
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ¸»·¹À̽þÆ
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ÀϺ»
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - Àεµ³×½Ã¾Æ
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - Çѱ¹
  • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Ç×±Õ ÁöÇ÷ Á© ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Ç×±Õ ÁöÇ÷ Á© ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - À̽º¶ó¿¤
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
  • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : Ç×±Õ ÁöÇ÷ Á© ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : Ç×±Õ ÁöÇ÷ Á© ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ¸ß½ÃÄÚ
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ºê¶óÁú
    • Ç×±Õ ÁöÇ÷ Á© ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª

Á¦8Àå °æÀï ±¸µµ

  • È®Àå ¹× Àμö ºÐ¼®
    • È®Àå
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦9Àå ±â¾÷ °³¿ä

  • DEXX laboratories inc
  • Medura
  • Pfizer
  • StopBleed
  • Zoetis Inc
LSH 23.09.15

The global antibacterial haemostatic gels market size is expected to reach USD 2,452.94 million by 2032, according to a new study by Polaris Market Research. The report "Antibacterial Haemostatic Gels Market Share, Size, Trends, Industry Analysis Report, By Product Type (Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices, and Others); By End User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The surge in product development is one of the prime aspects boosting the market's growth worldwide. Manufacturers are investing in research and development to create innovative formulations of antibacterial hemostatic gels. This involves exploring new ingredients, combinations, and technologies to develop gels with unique properties. Companies are continuously working on developing antibacterial hemostatic gels that are easy to apply and offer convenience for both healthcare providers and patients. For example, in April 2021, Rapid-Seal, a high-performance, antibacterial hemostatic gel, was introduced by Mercury. Likewise, many other businesses are investing in various products, further boosting the market's growth.

Chronic wounds, such as diabetic foot, pressure, and venous leg ulcers, are a growing healthcare concern worldwide. Antibacterial hemostatic gels play a vital role in wound management by controlling bleeding, preventing infection, and promoting healing. The rising incidence of chronic wounds is driving the demand for these gels. In addition to this, there has been a significant increase in public awareness regarding the importance of effective wound care management. Patients and healthcare professionals increasingly recognize the benefits of using antibacterial hemostatic gels for wound healing, leading to increased market demand.

The increasing healthcare expenditure in both developed and developing economies contributes to the growth of the antibacterial hemostatic gels market. Governments and healthcare organizations are investing in advanced wound care products, including antibacterial hemostatic gels, to improve patient outcomes and reduce healthcare costs associated with complications. For instance, the federal government (34 percent) and private households (27 percent) contributed the greatest portions of the overall health expenditures. In 2021, hospital spending increased by 4.4% to $1,323.9 Million. Enhancement in healthcare expenditure is helping to improve the sales of hemostatic gels worldwide. This further broadens the market's growth with a significant growth rate globally.

Antibacterial Haemostatic Gels Market Report Highlights

Urinanalysis testing kits segment dominated the global market in fiscal year in 2022 due to improving the effectiveness, ease of use, and patient outcomes

Hospital segment dominated the segment in terms of revenue share in the 2022 due to increasing wide range of surgical procedures

North America held the largest market share by the end of 2022 due to advanced healthcare infrastructure and technological advancements

The global antibacterial haemostatic gels market involves DEXX laboratories inc, Medura, StopBleed, Zoetis Inc., Pfizer, and others

Polaris Market Research has segmented the Antibacterial Haemostatic Gels market report based on product type, end user, and region:

Antibacterial Haemostatic Gels, Product Type Outlook (Revenue - USD Million, 2019-2032)

  • Urinanalysis Testing Kits
  • Hematology Testing Kits
  • Blood Pressure Monitoring Devices
  • Blood Glucose Monitoring Devices
  • Others

Antibacterial Haemostatic Gels, End User Outlook (Revenue - USD Million, 2019-2032)

  • Homecare
  • Diagnostic Centres
  • Hospitals
  • Clinics
  • Others

Antibacterial Haemostatic Gels, Regional Outlook (Revenue - USD Million, 2019-2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Antibacterial Haemostatic Gels Market Insights

  • 4.1. Antibacterial Haemostatic Gels Market - Industry Snapshot
  • 4.2. Antibacterial Haemostatic Gels Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising chronic diseases
      • 4.2.1.2. Increasing surgical procedures across many countries
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent Regulatory Approval Processes
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Antibacterial Haemostatic Gels Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Antibacterial Haemostatic Gels Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Antibacterial Haemostatic Gels, by Product Type, 2019-2032 (USD Million)
  • 5.3. Urinanalysis Testing Kits
    • 5.3.1. Global Antibacterial Haemostatic Gels Market, by Urinanalysis Testing Kits, by Region, 2019-2032 (USD Million)
  • 5.4. Hematology Testing Kits
    • 5.4.1. Global Antibacterial Haemostatic Gels Market, by Hematology Testing Kits, by Region, 2019-2032 (USD Million)
  • 5.5. Blood Pressure Monitoring Devices
    • 5.5.1. Global Antibacterial Haemostatic Gels Market, by Blood Pressure Monitoring Devices, by Region, 2019-2032 (USD Million)
  • 5.6. Blood Glucose Monitoring Devices
    • 5.6.1. Global Antibacterial Haemostatic Gels Market, by Blood Glucose Monitoring Devices, by Region, 2019-2032 (USD Million)
  • 5.7. Others
    • 5.7.1. Global Antibacterial Haemostatic Gels Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Antibacterial Haemostatic Gels Market, by End User

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
  • 6.3. Homecare
    • 6.3.1. Global Antibacterial Haemostatic Gels Market, by Homecare, by Region, 2019-2032 (USD Million)
  • 6.4. Diagnostic Centres
    • 6.4.1. Global Antibacterial Haemostatic Gels Market, by Diagnostic Centres, by Region, 2019-2032 (USD Million)
  • 6.5. Hospitals
    • 6.5.1. Global Antibacterial Haemostatic Gels Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 6.6. Clinics
    • 6.6.1. Global Antibacterial Haemostatic Gels Market, by Clinics, by Region, 2019-2032 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Antibacterial Haemostatic Gels Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Antibacterial Haemostatic Gels Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Antibacterial Haemostatic Gels Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Antibacterial Haemostatic Gels Market - North America
    • 7.3.1. North America: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
    • 7.3.2. North America: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.3.3. Antibacterial Haemostatic Gels Market - U.S.
      • 7.3.3.1. U.S.: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.3.4. Antibacterial Haemostatic Gels Market - Canada
      • 7.3.4.1. Canada: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
  • 7.4. Antibacterial Haemostatic Gels Market - Europe
    • 7.4.1. Europe: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
    • 7.4.2. Europe: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.4.3. Antibacterial Haemostatic Gels Market - UK
      • 7.4.3.1. UK: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.4.4. Antibacterial Haemostatic Gels Market - France
      • 7.4.4.1. France: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.4.4.2. France: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.4.5. Antibacterial Haemostatic Gels Market - Germany
      • 7.4.5.1. Germany: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.4.6. Antibacterial Haemostatic Gels Market - Italy
      • 7.4.6.1. Italy: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.4.7. Antibacterial Haemostatic Gels Market - Spain
      • 7.4.7.1. Spain: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.4.8. Antibacterial Haemostatic Gels Market - Netherlands
      • 7.4.8.1. Netherlands: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.4.9. Antibacterial Haemostatic Gels Market - Russia
      • 7.4.9.1. Russia: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
  • 7.5. Antibacterial Haemostatic Gels Market - Asia Pacific
    • 7.5.1. Asia Pacific: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.5.3. Antibacterial Haemostatic Gels Market - China
      • 7.5.3.1. China: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.5.3.2. China: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.5.4. Antibacterial Haemostatic Gels Market - India
      • 7.5.4.1. India: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.5.4.2. India: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.5.5. Antibacterial Haemostatic Gels Market - Malaysia
      • 7.5.5.1. Malaysia: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.5.6. Antibacterial Haemostatic Gels Market - Japan
      • 7.5.6.1. Japan: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.5.7. Antibacterial Haemostatic Gels Market - Indonesia
      • 7.5.7.1. Indonesia: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.5.8. Antibacterial Haemostatic Gels Market - South Korea
      • 7.5.8.1. South Korea: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
  • 7.6. Antibacterial Haemostatic Gels Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.6.3. Antibacterial Haemostatic Gels Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.6.4. Antibacterial Haemostatic Gels Market - UAE
      • 7.6.4.1. UAE: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.6.5. Antibacterial Haemostatic Gels Market - Israel
      • 7.6.5.1. Israel: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.6.6. Antibacterial Haemostatic Gels Market - South Africa
      • 7.6.6.1. South Africa: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
  • 7.7. Antibacterial Haemostatic Gels Market - Latin America
    • 7.7.1. Latin America: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.7.3. Antibacterial Haemostatic Gels Market - Mexico
      • 7.7.3.1. Mexico: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.7.4. Antibacterial Haemostatic Gels Market - Brazil
      • 7.7.4.1. Brazil: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)
    • 7.7.5. Antibacterial Haemostatic Gels Market - Argentina
      • 7.7.5.1. Argentina: Antibacterial Haemostatic Gels Market, by End User, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Antibacterial Haemostatic Gels Market, by Product Type, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. DEXX laboratories inc
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Medura
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Pfizer
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. StopBleed
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Zoetis Inc
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦